Skip to content
value.today

SiNtx Technologies, Inc.

SINT
$13 Mmarket cap on Oct 30, 2026+557.5% since Jan 2024
Compare
World rank
#25,359
Revenue
$1 M
For year ending December-2025
Net income
$-10 M
-1015.7% margin
SEC filing
Employees
32
As of December 31, 2025
SEC filing

SiNtx Technologies, Inc. in brief

SiNtx Technologies, Inc. is a listed company in the Medical Devices industry, based in Salt Lake City, Utah, USA. Its market value was $13 M on 30 October 2026, which makes it the 25,359th largest listed company in the world and the 4,236th largest in the USA on this site. In the year to December 2025 it had sales of $1 M and a net loss of $10 M. It employs about 32 people and Eric K. Olson is its chief executive. Its largest product and service lines by sales in 2025 were Grant and Contract (28%). Its shares trade under the symbol SINT (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About SiNtx Technologies, Inc.

SINTX Technologies is an advanced ceramics company formed in December 1996 that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX provides biomedical solutions for medical devices specializing in silicon nitride (Si₃N₄) for musculoskeletal and antipathogenic applications. We also manufacture parts made from silicon nitride for customers in the electrical, aerospace and other industrial sectors. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008.

From the company's annual report filed with the US SEC: read the report

SiNtx Technologies, Inc. timeline

4 events, 2003–2024
  1. 2003
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2014
  4. 🔔
    Initial public offering as Amedica Corp
    Final prospectus filed with the SEC on 14 February 2014; shares registered for exchange trading on 7 February 2014.
  5. 2018
  6. ✎
    Renamed Sintx Technologies, Inc.
    Formerly Amedica Corp.
  7. 2024
  8. 💰
    Record revenue of $3 million
    FY2024, the highest of the 7 years on record.

Events of SiNtx Technologies, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$11 M$22 M$32 M$43 M2020202120222023202420252026

World rank over time

▲ up 2,389 places since 2020
2020-01-01: #27756#27,75620202021-01-01: #21372#21,37220212022-01-07: #30467#30,46720222022-12-25: #33001#33,00120222023-07-30: #32834#32,83420232024-01-05: #33582#33,58220242026-03-08: #12679#12,67920262026-08-01: #22843#22,84320262026-10-14: #25009#25,00920262026-10-30: #25367#25,3672026

Rank in USA: #4,845 (Jan 2020) · #4,161 (Jan 2021) · #5,488 (Jan 2022) · #5,809 (Dec 2022) · #5,575 (Jul 2023) · #4,726 (Jan 2024) · #2,370 (Mar 2026) · #4,033 (Aug 2026) · #4,160 (Oct 2026) · #4,238 (Oct 2026)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
12.9×
Price / book
4.5×
Free cash flow yield
-66.5%
Net margin
-1015.7%
Operating margin
-1051.0%
Return on equity
-353.6%
Liabilities / assets
69.2%
Net debt
$-6M
Revenue growth
-64.7%
R&D / revenue
450.0%
Revenue per employee
$32 K
Profit per employee
$-324 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-9M—FY18Fiscal year ending Dec 2019: revenue $1M, net income $-5M$1MFY19Fiscal year ending Dec 2020: revenue $1M, net income $-7M$1MFY20Fiscal year ending Dec 2021: revenue $1M, net income $-9M$1MFY21Fiscal year ending Dec 2022: revenue $2M, net income $-12M$2MFY22Fiscal year ending Dec 2023: revenue $3M, net income $-8M$3MFY23Fiscal year ending Dec 2024: revenue $3M, net income $-11M$3MFY24Fiscal year ending Dec 2025: revenue $1M, net income $-10M$1MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$1M-64.7%$-11M$-10M-1015.7%
Dec 2024$3M+9.9%$-14M$-11M-381.3%
Dec 2023$3M+68.6%$-13M$-8M-314.1%
Dec 2022$2M+155.7%$-11M$-12M-771.8%
Dec 2021$1M+3.4%$-11M$-9M-1526.2%
Dec 2020$1M-14.5%$-9M$-7M-1191.5%
Dec 2019$1M—$-7M$-5M-695.7%
Dec 2018——$-13M$-9M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-9M$0M$-9M$-6.16—
Dec 2024$-9M$1M$-9M$-15.19—
Dec 2023$-14M$1M$-15M$-624.47—
Dec 2022$-10M$1M$-12M$-60.81—
Dec 2021$-10M$4M$-14M$-39.91—
Dec 2020$-9M$0M$-9M$-1.08—
Dec 2019$-6M$0M$-7M$-5.69—
Dec 2018$-9M$0M$-9M$-76.73—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $1M, net income $-2M$1MDec ’24Three months to Mar 2025: revenue $0M, net income $-2M$0MMar ’25Three months to Jun 2025: revenue $0M, net income $-2M$0MJun ’25Three months to Sep 2025: revenue $0M, net income $-4M$0MSep ’25Three months to Dec 2025 (from the annual report): revenue $0M, net income $-2M$0MDec ’25Three months to Mar 2026: revenue $0M, net income $-3M$0MMar ’26Three months to Jun 2026: revenue $0M, net income $-3M$0MJun ’26Three months to Sep 2026: revenue $2M, net income $-2M$2MSep ’26

Latest quarter to Sep 2026: revenue $2M (+942.9% on a year earlier), net income $-2M. Lighter bars: fourth quarters worked out from the annual report.

SEC filings

Official filings of SiNtx Technologies, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$1 M
Operating income
$-11 M
Net income
$-10 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$10 M
Total liabilities
$7 M
Total equity
$3 M

As of December-2025

Top 22 institutional investors in SiNtx Technologies, Inc.#

As of Sep 30, 2026
22 institutions held 958,633 shares (about 12.7% of the shares outstanding) on Sep 30, 2026. The ten largest hold 12.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 22 largest institutional investors in SiNtx Technologies, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Bleichroeder LP523,0130 (0.00%)6.92%$1 MNov 13, 2026
2Stonepine Capital Management, LLC233,936+24,731 (+11.82%)3.10%$1 MNov 13, 2026
3Veracity Capital LLC76,6740 (0.00%)1.01%$0 MOct 8, 2026
4Geode Capital Management, LLC25,117-4,984 (-16.56%)0.33%$0 MNov 6, 2026
5Vanguard Fiduciary Trust Co23,5310 (0.00%)0.31%$0 MNov 13, 2026
6Vanguard Capital Management LLC20,9050 (0.00%)0.28%$0 MNov 13, 2026
7Citadel Advisors LLC17,209-14,721 (-46.10%)0.23%$0 MNov 16, 2026
8State Street Corp13,3020 (0.00%)0.18%$0 MNov 12, 2026
9Northern Trust Corp10,816New0.14%$0 MNov 16, 2026
10Virtus Wealth Solutions LLC10,0000 (0.00%)0.13%$0 MNov 3, 2026
11Tower Research Capital LLC (TRC)1,849-1,001 (-35.12%)0.02%$0 MNov 16, 2026
12UBS Group AG1,598-10,323 (-86.60%)0.02%$0 MNov 10, 2026
13Signaturefd, LLC573-1,144 (-66.63%)0.01%$0 MOct 23, 2026
14FMR LLC50New0.00%$0 MNov 10, 2026
15Royal Bank Of Canada40+1 (+2.56%)0.00%$0 MNov 16, 2026
16SBI Securities Co., Ltd.140 (0.00%)0.00%$0 MOct 22, 2026
17US Bancorp \de\1New0.00%$0 MNov 5, 2026
18Morgan Stanley10 (0.00%)0.00%$0 MNov 13, 2026
19National Bank Of Canada /fi/10 (0.00%)0.00%$0 MNov 16, 2026
20Allworth Financial LP10 (0.00%)0.00%$0 MNov 17, 2026
21Cassaday & Co Wealth Management LLC1New0.00%$0 MOct 27, 2026
22BFC Planning, Inc.10 (0.00%)0.00%$0 MNov 13, 2026

Mutual funds holding SiNtx Technologies, Inc.#

6 funds hold shares worth $0 M (about 0.6% of the company). Since their previous reports 1 added shares and 1 sold.
Mutual funds holding SiNtx Technologies, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC18,832$0 M0.25%<0.01%−0.8%May 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.20,905$0 M0.28%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC4,288$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC1,861$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP1,373$0 M0.02%<0.01%newJul 31, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC43$0 M<0.01%<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 6 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at SiNtx Technologies, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$326 K
19 purchases, 4 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$326 K
open market only
Insiders on file
20
since
$290 K$0Apr 2025: bought $65 K (11 trades), sold $0 (0 trades)Apr 25Jun 2025: bought $33 K (1 trades), sold $0 (0 trades)JunAug 2025: bought $233 K (15 trades), sold $0 (0 trades)AugOct 2025: bought $20 K (1 trades), sold $0 (0 trades)OctNov 2025: bought $32 K (2 trades), sold $0 (0 trades)NovDec 2025: bought $290 K (15 trades), sold $0 (0 trades)DecFeb 2026: bought $14 K (3 trades), sold $0 (0 trades)FebMar 2026: bought $22 K (1 trades), sold $0 (0 trades)Mar
Bought (open market)Sold (open market)Hover a month for the totals
SiNtx Technologies, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Robert Ryan ElmorePresidentGrant or award+4,910$2.890$14 K4,910Form 4
filed Christopher Michael LyonsDirectorBuy+7,534$2.900$22 K8,292Form 4
filed Christopher Michael LyonsDirectorBuy+758$2.960$2 K758Form 4
filed Jay M. MoyesDirectorBuy+1,000$2.910$3 K4,000Form 4
filed Mark Lewis AndersonDirectorBuy+3,000$3.020$9 K18,000Form 4
filed Gregg R. HonigblumChief Investment Officer, DirectorBuy+3,200$4.280$14 K196,067Form 4
filed Gregg R. HonigblumChief Investment Officer, DirectorBuy+5,000$4.240$21 K201,067Form 4
filed Gregg R. HonigblumChief Investment Officer, DirectorBuy+5,000$3.950$20 K79,000Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: SiNtx Technologies, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
128,437
3.2% of shares · 7.29 days to cover
Buybacks, Q4 2025
$0M
Q4 2025
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-25.84 reverse split

SiNtx Technologies, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q4 2025Q4 2025$0M
Q3 2025Q3 2025$0M
Q2 2025Q2 2025$0M
Q1 2025Q1 2025$0.1M
Q4 2015Q4 2015$0M
Q3 2015Q3 2015$0M
Q2 2015Q2 2015$0M
Q1 2015Q1 2015$0.1M
Q3 2014Q3 2015$0M
Q2 2014Q2 2015$0M
Q1 2014Q1 2015$0M

Trading halts

  • 2025-09-03 14:08 UTC, code LUDP, resumed 14:13 UTC
  • 2025-09-03 14:02 UTC, code LUDP, resumed 14:07 UTC
  • 2025-02-21 15:06 UTC, code LUDP, resumed 15:11 UTC
  • 2025-02-21 14:58 UTC, code LUDP, resumed 15:03 UTC

Fails to deliver

  • : 212 shares at $1.74
  • : 1 shares at $1.71
  • : 87 shares at $1.56
  • : 7 shares at $1.72
  • : 450 shares at $1.82

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

SiNtx Technologies, Inc. scorecard#

Passes 2 of the 20 checks that could be worked out: strongest in financial health (1 of 3), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation0 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median4.5×Price to book 4.5× against Medical Devices's median of 2.5×.
    • ✗Price to sales below its peers' median12.9×Price to sales 12.9× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-66.5%Free cash flow is -66.5% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 6
    • ✗Revenue grew in the newest year-64.7%Revenue down 64.7% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-13.2%-13.2% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-13.2%-13.2% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-6.16 vs -15.19Diluted EPS -6.16 in fiscal 2025 against -15.19 the year before (report's currency).
    • ✗Net income higher than five years earlier-$10 M-$10 M in fiscal 2025 against -$7 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$10 MNet income -$10 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%-303.8%-303.8% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 3
    • ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.51 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-45.17Z-score -45.17 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year272.4%Diluted shares up 272.4% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value1.0%Dividends and buybacks were 1.0% of the market value.
    • ✗Free cash flow covers dividends and buybacks-$9 MFree cash flow -$9 M against $0 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from SiNtx Technologies, Inc.'s statements, beside the median of Medical Devices.

SiNtx Technologies, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Return on equity-303.8%-16.8%
Revenue growth, 3 years a year-13.2%10.8%
Revenue growth-64.7%10.4%
Free cash flow margin-857.8%-1.9%

2of 8on the Piotroski tests of financial strength

  • Revenue fell 64.7% against the year before.
  • Net loss of $10 million, the 13th loss-making year in a row.
  • Free cash flow was negative: -$9 million.
  • The share count rose 272.4% in the year.

SiNtx Technologies, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

SiNtx Technologies, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue1.02.92.61.60.60.60.70.11115
Cost of revenue0.60.80.80.30.40.50.60.16.43.8
Gross profit0.52.11.81.30.20.10.10.04.911
Research and development4.65.28.76.55.94.83.43.03.5r6.3
Selling and marketing0.20.61.11.31.30.70.40.10.3r10
General and administrative6.24.04.24.03.63.12.93.93.7r6.3
Operating expenses11161513118.66.7137.5r23
Operating income−11−14−13−11−11−8.5−6.6−13−7.5r−12
Other non-operating income (expense)0.43.05.1−0.71.3r1.51.83.41.7−3.2r
Income before tax−10−11−8.3−12−9.3r−7.0−4.8−9.7−5.8r−15r
Income from discontinued operations———————−0.3——
Net income attributable to shareholders−10−11−8.3−12−9.3r−7.0−4.8−8.7−9.3−15r
Earnings per share, basic-6.16-14.87-443.47r-54.67-37.70r-1.01-4.82-61.85r-3.13-13.63r
Earnings per share, diluted-6.16-15.19-624.47r-60.81-39.91r-1.08-5.69-76.73r-3.13-13.63r
Shares, weighted average (basic)2.80.70.0r0.30.2r161.60.4r3.0—
Shares, weighted average (diluted)2.80.70.0r0.30.3r171.60.4r3.01.5r
Balance sheet
Cash and cash equivalents4.13.63.36.214251.85.40.56.9
Receivables———————0.31.21.6
Inventory0.80.50.9r0.70.60.50.60.7r0.7r7.2
Other current assets0.50.00.10.00.40.20.30.20.20.2
Current assets5.74.5r5.57.215284.17.03.7r16
Property, plant and equipment0.50.94.85.74.00.50.20.10.2r0.9
Right-of-use (leased) assets2.53.24.12.32.41.92.3———
Goodwill0.3———————6.26.2
Other intangible assets0.10.00.00.00.00.00.00.02.73.2
Total assets9.59.4151622309.1121526
Accounts payable0.40.30.60.40.2r0.20.20.31.70.7
Debt due within a year0.00.00.00.20.50.10.0—0.67.0
Current liabilities3.72.02.98.12.7r2.92.12.48.314r
Long-term debt———0.4—0.30.0——12
Lease liabilities (non-current)2.83.53.71.61.91.51.9———
Total liabilities6.65.56.6104.6r4.63.93.19.215r
Retained earnings−292−282−271−262−250r−241−234−229−221−211r
Shareholders' equity2.93.98.85.717r265.28.4r5.411r
Total liabilities and equity9.59.4151622309.1121526
Shares outstanding4.01.30.0r0.50.2r252.40.7r3.02.3r
Cash-flow statement
Share-based compensation1.40.10.30.40.30.00.00.00.20.3
Cash from operating activities−8.6−8.6−14−10−10r−9.1−6.4−9.3−4.7−7.2
Capital expenditure−0.2−0.7−0.5−1.4−3.7r−0.4−0.1−0.0−0.0r−0.7
Intangible assets bought———————−0.1——
Cash from investing activities0.9−0.2−0.5−1.1−1.7r1.81.4−0.1−1.1−0.6
Debt issued————0.50.4—0.72.5—
Debt repaid−0.2−0.3−0.1−0.5—−0.0−0.0−2.3−6.8−6.6
Shares issued4.46.15.2——201.5—3.12.5r
Shares bought back−0.1—————————
Cash from financing activities8.29.1123.30.7311.414−0.63.2
Change in cash0.50.3−2.9−8.0−1124−3.74.9−6.4−4.6
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What SiNtx Technologies, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Product(total)$1 M72%
  • Grant and Contract$0 M28%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at SiNtx Technologies, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$1.1 M
Eric Olson
Other top executives, average
$753 K
the CEO earned 1.4× this
$100 invested is now
—
SiNtx Technologies, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Eric Olson$1.1 M$1.0 M$753 K—
2023Eric K. Olson$537 K$462 K$454 K—

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at SiNtx Technologies, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling

Delisting notice 1 · Directors and officers 8 · Material agreement 7 · Unregistered share sale 5 · Shareholder vote 2 · Results announced 5

SiNtx Technologies, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Results announced8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Delisting notice8-K
Directors and officers8-K
Results announced8-K
Material agreement8-K
Material agreementUnregistered share sale8-K
Directors and officersShareholder vote8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Directors and officers8-K
Material agreementUnregistered share sale8-K
Material agreement8-K
Shareholder vote8-K
Directors and officers8-K
Directors and officers8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026

Acquisitions and funding#

5 private funding rounds before listing

Private share sales · funding history

Private share sales of SiNtx Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2014$6 MNo. 5$2 to $10 million1debt, optionsSEC
Aug 2013$9 MNo. 4$2 to $10 million45equity, optionsSEC
Feb 2013$3 MNo. 3$2 to $10 million34equity, optionsSEC
Mar 2011$22 MNo. 2$10 to $50 million69debt, optionsSEC
Feb 2010$11 MNo. 1$10 to $50 million96equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Layoffs at SiNtx Technologies, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
46
2015–2016
Latest
21 people
2016-10-03
SiNtx Technologies, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2016·········21··21
201525···········25
SiNtx Technologies, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
21 people (38% of workforce)Restructuring planSEC 8-K“On October 3, 2016, the Board of Directors of Amedica Corporation authorized the implementation of certain cost saving measures which included a reduction in staff of 21 employees,…”Filing
25 people (28% of workforce)Restructuring planSEC 8-K“On January 7, 2015, the Board of Directors of Amedica Corporation authorized the implementation of certain cost saving measures which included a reduction in staff of 25 employees,…”Filing

Source: State WARN notices and SEC 8-K item 2.05

How SiNtx Technologies, Inc. compares in Medical Devices

  • Market cap$13 M · higher than 8% of 142
  • Revenue$1 M · higher than 7% of 155
  • Revenue growth-64.7% · higher than 2% of 104
  • Price / sales12.9× · lower than 6% of 96
  • Price / book4.5× · lower than 33% of 99
  • FCF yield-66.5% · higher than 9% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
SiNtx Technologies, Inc.🇺🇸$13 M——-64.7%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at SiNtx Technologies, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show SiNtx Technologies, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about SiNtx Technologies, Inc.? Suggest a correction